Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin.
Kotridis P, Kokkas B, Kyriakou P, Karamouzis M, Salpigidis G, Karantona C, Karadoumanis J, Ginis T, Goulis O, Papadopoulos PC, Vakalopoulos C, Sakantamis G, Dimitriadou A, Mirtsou-Fidani V, Papadopoulos CL.
Kotridis P, et al. Among authors: karamouzis m.
Eur J Drug Metab Pharmacokinet. 2003 Apr-Jun;28(2):143-6. doi: 10.1007/BF03190503.
Eur J Drug Metab Pharmacokinet. 2003.
PMID: 12877573